High-efficiency clean air delivery and bio-molecular scrubbing systems engineered to meet ISO 14644-1 and cGMP biological standard requirements.
Addressing molecular gaseous contamination, volatile organic compounds, and microbiological containment in contemporary life science research.
In advanced biotechnology research laboratories—encompassing recombinant DNA research, cellular and gene therapies, stem cell culturing, and high-throughput proteomics—traditional particulate filtration (HEPA and ULPA) is essential but no longer sufficient on its own. While high-efficiency particulate air filters successfully capture bacteria, fungal spores, and sub-micron aerosols down to 0.1 microns, they remain transparent to gaseous contaminants, volatile organic compounds (VOCs), and airborne molecular contaminants (AMCs).
Gaseous micro-pollutants such as trace formaldehyde, phenol-chloroform vapors, isopropyl alcohol, xylene, and biological off-gassing agents present profound risks. These airborne chemical agents can diffuse directly into liquid culture media, subtly shift pH balances, disrupt cellular proliferation curves, and introduce unintended epigenetic variations into delicate stem cell lines. Consequently, the integration of advanced activated carbon air filtration matrices alongside HEPA systems has transitioned from an optional enhancement to an imperative baseline for Grade A/B laboratory cleanrooms and BSL-3/BSL-4 biocontainment facilities.
Tailored micro-porous (
Chemical modification with potassium iodide (KI), KOH, or phosphoric acid neutralizes stubborn acidic gases, amines, and formaldehyde.
Non-woven synthetic binding and downstream micro-scrim membranes prevent carbon dust release into sterile cell processing suites.
The global biotechnology cleanroom air filtration market is undergoing rapid evolution propelled by stricter international regulatory frameworks including cGMP Annex 1 (2022 revision), ISO 14644-8 (Classification of airborne molecular contamination), and ASHRAE Standard 145.2. Facility managers are under intense pressure to maintain continuous compliance while lowering overall lifecycle carbon footprints.
Modern biotechnology facilities increasingly utilize recirculating air systems with advanced chemical adsorption beds to minimize expensive conditioned outdoor air intake. High-efficiency activated carbon filters with low aerodynamic pressure drop allow biotech facilities to achieve up to 40% reduction in HVAC thermal energy consumption while guaranteeing AMC suppression below parts-per-billion (ppb) thresholds.
The application of activated carbon air filtration manifests distinct operational nuances across differing biotech spaces:
K-STONE Cleanroom System Engineering (Suzhou) Co., Ltd. is a professional cleanroom system supplier specializing in the design and construction of cleanroom engineering projects. With nearly 20 years of industry experience, our core team brings extensive expertise and deep understanding of cleanroom technologies and standards.
Founded in 2012, K-STONE has positioned itself as a trusted partner offering complete cleanroom solutions—from conceptual design to system integration and execution. We serve a wide range of industries, including pharmaceuticals, biotechnology, electronics, and medical applications, with a strong focus on tailored engineering services that meet the specific needs of each client.
At K-STONE, we are committed to creating value for our customers. Our services include engineering consultation, layout design, construction, and cleanroom system commissioning and operation, ensuring a seamless project delivery experience.



Established in 2019, Zhejiang Ailv Purification Technology Co., Ltd. is K-STONE’s dedicated manufacturing arm, located in Meixi Industrial Park, Anji, Zhejiang Province. The facility spans 30 acres with a self-built factory of approximately 30,000 square meters.
The factory is equipped with state-of-the-art production lines and testing equipment, enabling high-precision manufacturing of cleanroom components including:
Our products are widely applied in biomedical, food processing, electronics, semiconductors, new energy, and medical aesthetics industries. By integrating design, production, and quality control, we ensure high-performance, reliable cleanroom solutions for global customers.
To become a leading force in the global cleanroom industry.
K-STONE is committed to driving innovation and setting new benchmarks in clean environment engineering.
Quality first, pursuit of excellence.
We strive to deliver high-performance cleanroom solutions through uncompromising quality and continuous improvement.
Professionalism. Dedication. Customer Value.
We are driven by a strong sense of responsibility, expertise, and the belief that our success is measured by the value we create for our clients.
At K-STONE, we go beyond supplying products—we deliver confidence, innovation, and long-term value.

Our rigorous quality standards and attention to detail ensure every product and project meets international compliance and client expectations.

We invest heavily in the research and development of new products, technologies, and materials to stay at the forefront of the cleanroom industry.

We have a highly experienced team specializing in cleanroom design, construction, and execution—ensuring efficiency, compliance, and reliable performance from concept to completion.




K-STONE offers fully integrated engineering solutions for pharmaceutical and medical manufacturing plants around the world. Our turnkey capabilities cover every critical aspect of facility development, including:
We understand that each project must meet stringent regulatory requirements across different countries, while also adapting to the specific operational needs of each client. By providing customized, regulation-compliant turnkey solutions, K-STONE empowers pharmaceutical manufacturers to achieve high performance, global compliance, and strong industry recognition.












From coarse pre-filtration to chemical molecular adsorption and high-velocity biological air de-dusting showers.